Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 72789-268

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 72789-268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789268 Label (72789268)

Label for PANTOPRAZOLE SODIUM DR USP 40 mg delayed release tablets, containing 30 tablets per package. The label includes the NDC 72789-268-30, manufacturer PD-Rx Pharmaceuticals, Inc. in Oklahoma City, OK, and batch details like lot H22C31 with expiration 02/2024. The label also has dosing and safety warnings.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of pantoprazole, the active ingredient in PANTOPRAZOLE SODIUM 40 mg delayed-release tablets. The structure includes a difluoromethoxy substituent, a benzimidazole ring system, and a pyridine ring, along with associated sodium and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.